Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291200 · ClinicalTrials.gov registry record
Enhancing the Prospective Prediction of Psychosis
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 268
- Enrollment target
NCT00291200: Completed study, sponsored by Yale University.
NCT00291200 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 268 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00291200 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 268 participants
- Enrollment target
Study Summary
This study will gather information on the natural history of the basic symptoms of psychosis to identify factors that may affect the improvement or persistence of the symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2003-08 |
| Est. Completion | 2009-02 |
What the finished NCT00291200 record still lists
NCT00291200 is an observational study that tracks outcomes without assigning an intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00291200 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00291200 about?
NCT00291200 is a clinical study titled "Enhancing the Prospective Prediction of Psychosis". This study will gather information on the natural history of the basic symptoms of psychosis to identify factors that may affect the improvement or persistence of the symptoms.
What is the current status of trial NCT00291200?
This trial is currently completed. The enrollment target is 268 participants. The study started on 2003-08. Estimated completion is 2009-02.
Who is sponsoring clinical trial NCT00291200?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia